AMAT
60
-5
PHM
44
-3
EFX
58
-8
NAVI
21
-8
KMI
38
-2
WEC
62
-6
FMC
29
-8
CB
44
-3
EOG
55
5
EQR
31
-5
FFIV
61
-6
LOW
42
-4
TXT
69
-3
ACN
47
-7
SJM
2
-4
AXP
60
-7
JCI
59
-2
EXR
51
-4
TEL
54
-7
ES
37
-3
AMAT
60
-5
PHM
44
-3
EFX
58
-8
NAVI
21
-8
KMI
38
-2
WEC
62
-6
FMC
29
-8
CB
44
-3
EOG
55
5
EQR
31
-5
FFIV
61
-6
LOW
42
-4
TXT
69
-3
ACN
47
-7
SJM
2
-4
AXP
60
-7
JCI
59
-2
EXR
51
-4
TEL
54
-7
ES
37
-3
Financhill
Sell
41

ABUS Quote, Financials, Valuation and Earnings

Last price:
$3.53
Seasonality move :
11.13%
Day range:
$3.49 - $3.60
52-week range:
$2.71 - $4.73
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
104.40x
P/B ratio:
8.54x
Volume:
515.4K
Avg. volume:
738.4K
1-year change:
11.71%
Market cap:
$676.1M
Revenue:
$6.2M
EPS (TTM):
-$0.41

Arbutus Biopharma SEC Filings

Company Filed Form Type Description
ABUS
Arbutus Biopharma
 11/07/2023 10-Q 10-Q filing on 11/07/2023 View Form
ABUS
Arbutus Biopharma
 08/03/2023 10-Q 10-Q filing on 08/03/2023 View Form
ABUS
Arbutus Biopharma
 05/04/2023 10-Q 10-Q filing on 05/04/2023 View Form
ABUS
Arbutus Biopharma
 11/09/2022 10-Q 10-Q filing on 11/09/2022 View Form
ABUS
Arbutus Biopharma
 08/04/2022 10-Q 10-Q filing on 08/04/2022 View Form
ABUS
Arbutus Biopharma
 05/05/2022 10-Q 10-Q filing on 05/05/2022 View Form
ABUS
Arbutus Biopharma
 11/04/2021 10-Q 10-Q filing on 11/04/2021 View Form
ABUS
Arbutus Biopharma
 08/05/2021 10-Q 10-Q filing on 08/05/2021 View Form
ABUS
Arbutus Biopharma
 05/05/2021 10-Q 10-Q filing on 05/05/2021 View Form
ABUS
Arbutus Biopharma
 11/05/2020 10-Q 10-Q filing on 11/05/2020 View Form
ABUS
Arbutus Biopharma
 08/07/2020 10-Q 10-Q filing on 08/07/2020 View Form
ABUS
Arbutus Biopharma
 05/11/2020 10-Q 10-Q filing on 05/11/2020 View Form
ABUS
Arbutus Biopharma
 03/06/2020 10-K 10-K filing on 03/06/2020 View Form
ABUS
Arbutus Biopharma
 03/05/2020 10-K 10-K filing on 03/05/2020 View Form
ABUS
Arbutus Biopharma
 11/06/2019 10-Q 10-Q filing on 11/06/2019 View Form
ABUS
Arbutus Biopharma
 08/05/2019 10-Q 10-Q filing on 08/05/2019 View Form
ABUS
Arbutus Biopharma
 05/06/2019 10-Q 10-Q filing on 05/06/2019 View Form
ABUS
Arbutus Biopharma
 03/07/2019 10-K 10-K filing on 03/07/2019 View Form
ABUS
Arbutus Biopharma
 11/07/2018 10-Q 10-Q filing on 11/07/2018 View Form
ABUS
Arbutus Biopharma
 08/03/2018 10-Q 10-Q filing on 08/03/2018 View Form
ABUS
Arbutus Biopharma
 05/04/2018 10-Q 10-Q filing on 05/04/2018 View Form
ABUS
Arbutus Biopharma
 03/16/2018 10-K 10-K filing on 03/16/2018 View Form
ABUS
Arbutus Biopharma
 11/02/2017 10-Q 10-Q filing on 11/02/2017 View Form
ABUS
Arbutus Biopharma
 08/03/2017 10-Q 10-Q filing on 08/03/2017 View Form
ABUS
Arbutus Biopharma
 05/17/2017 10-K 10-K filing on 05/17/2017 View Form
ABUS
Arbutus Biopharma
 05/04/2017 10-Q 10-Q filing on 05/04/2017 View Form
ABUS
Arbutus Biopharma
 03/22/2017 10-K 10-K filing on 03/22/2017 View Form
ABUS
Arbutus Biopharma
 12/22/2016 10-Q 10-Q filing on 12/22/2016 View Form
ABUS
Arbutus Biopharma
 11/03/2016 10-Q 10-Q filing on 11/03/2016 View Form
ABUS
Arbutus Biopharma
 08/04/2016 10-Q 10-Q filing on 08/04/2016 View Form
ABUS
Arbutus Biopharma
 05/04/2016 10-Q 10-Q filing on 05/04/2016 View Form
ABUS
Arbutus Biopharma
 03/11/2016 10-K 10-K filing on 03/11/2016 View Form
ABUS
Arbutus Biopharma
 03/09/2016 10-K 10-K filing on 03/09/2016 View Form
ABUS
Arbutus Biopharma
 11/05/2015 10-Q 10-Q filing on 11/05/2015 View Form
ABUS
Arbutus Biopharma
 08/07/2015 10-Q 10-Q filing on 08/07/2015 View Form
ABUS
Arbutus Biopharma
 07/15/2015 10-Q 10-Q filing on 07/15/2015 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Free Training Webinar

Related Companies

Get ABUS Stock Alert

Signup to receive the latest stock alerts

Financial Ratios

ABUS
Sector
P/E ratio
--
24.57x
PEG ratio
--
0.00x
P/B ratio
8.54x
1.81x
Price / LTM sales
104.40x
1.68x

Growth Metrics

ABUS
Sector
Revenue growth
15.14%
4.5%
Earnings growth
--
7.63%
Revenue (5-year growth)
0.53%
8.17%
Earnings forecast
-$0.11
-$0.21

Profitability

ABUS
Sector
Profitability FY 2025
--
$50.5M
Return on invested capital
-73.56%
-14.96%
Return on assets
-54.73%
-12.24%
Return on equity
-73.56%
-17.05%

Earnings Date

Last Earnings Date
May
14
Next Earnings Date
Aug
1
Estimated Next Earnings Date
Aug
13

Balance Sheet

ABUS
Sector
Total cash
$112.7M
$37.7M
Short term investments
$86.3M
$31.7M
Total assets
$131.7M
$116.7M
Long term debt
--
$7.9M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Free Training Webinar

Popular

Is Palantir Stock Overvalued?
Is Palantir Stock Overvalued?

By every traditional yardstick, including a price‑to‑sales well above 100,…

Read article
Is Gamestop’s Bitcoin Strategy Going To Succeed?
Is Gamestop’s Bitcoin Strategy Going To Succeed?

When GameStop (NYSE: GME) announced in Q1 that its board had…

Read article
How High Will Roku Stock Go?
How High Will Roku Stock Go?

Streaming software and hardware maker Roku (NASDAQ:ROKU) has seen its…

Read article

Stock Ideas

Buy
65
Is MSFT Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 40x

Buy or Sell?
Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 48x

Buy or Sell?
Sell
39
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Buy or Sell?

Alerts

Sell
11
VEON alert for Jun 14

VEON [VEON] is down 18.57% over the past day.

Buy or Sell?
Buy
74
DAVE alert for Jun 14

Dave [DAVE] is down 12.68% over the past day.

Buy or Sell?
Buy
54
DAR alert for Jun 14

Darling Ingredients [DAR] is up 9.12% over the past day.

Buy or Sell?
Master Safe Stock Market Strategies
Get Paid To Own Stocks. Insure Your Stocks During Downtrends. Master "The Vacation Trade".

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock

Watchlist

Stock Score

Seasonality

Analyze

Covered Calls

Valuation

Smart Money

Education

E-Book

Newsletters

Companies

Dividends

Traders Library

Big Movers

Stock Ideas

Stocks by Sector